Amubarvimab Plus Romlusevimab Safe, Effective for COVID-19

WEDNESDAY, April 19, 2023 -- For nonhospitalized patients with COVID-19 at high risk for clinical progression, amubarvimab plus romlusevimab is safe and reduces the risk for hospitalization and/or death, according to a study published online April...